EXCISION REPAIR CROSS-COMPLEMENTING GROUP 1 (ERCC1) MAY PREDICT THE EFFICACY OF CHEMORADIOTHERAPY FOR BLADDER CANCER

被引：0
|
作者：
Kawashima, Atsunari
Nakayama, Masashi
Kakuta, Yoichi
Abe, Toyofumi
Sato, Mototaka
Hatano, Koji
Mukai, Masatoshi
Nagahara, Akira
Oka, Daizo
Nakai, Yasutomo
Takayama, Hitoshi
Yoshioka, Toshiaki
Hoshida, Yoshihiko
Itatani, Hiroaki
Nishimura, Kazuo
Nonomura, Norio
机构：
来源：
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.juro.2011.02.1206
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
510
引用
收藏
页码：E207 / E208
页数：2
相关论文
共 50 条
  • [21] Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer
    J Matsubara
    T Nishina
    Y Yamada
    T Moriwaki
    T Shimoda
    T Kajiwara
    T E Nakajima
    K Kato
    T Hamaguchi
    Y Shimada
    Y Okayama
    T Oka
    K Shirao
    British Journal of Cancer, 2008, 98 : 832 - 839
  • [22] Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer
    Matsubara, J.
    Nishina, T.
    Yamada, Y.
    Moriwaki, T.
    Shimoda, T.
    Kajiwara, T.
    Nakajima, T. E.
    Kato, K.
    Hamaguchi, T.
    Shimada, Y.
    Okayama, Y.
    Oka, T.
    Shirao, K.
    BRITISH JOURNAL OF CANCER, 2008, 98 (04) : 832 - 839
  • [23] Different Impact of Excision Repair Cross-Complementing Group 1 on Survival Reply
    Holm, Bente
    Mellemgaard, Anders
    Skov, Torsten
    Skov, Birgit Guldhammer
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) : E164 - E164
  • [24] RETRACTED: Chemoresistance in gastric cancer is attributed to the overexpression of excision repair cross-complementing 1 (ERCC1) caused by microRNA-122 dysregulation (Retracted Article)
    Song, Ai-Ling
    Zhao, Lei
    Wang, Yan-Wei
    He, Dong-Qiang
    Li, Yu-Min
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (12) : 22485 - 22492
  • [25] Excision repair cross-complementing group-1 (ERCC1) gene induction in peripheral blood mononuclear cells as a marker of outcome in patients with colorectal cancer treated with oxaliplatin.
    Rao, Devika
    Mallick, Atrayee Basu
    Merla, Amartej
    Jiffry, Jeeshan
    Chaudhary, Imran
    Augustine, Titto A.
    Rajdev, Lakshmi
    Kaubisch, Andreas
    Maitra, Radhashree
    Goel, Sanjay
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [26] The role of thymidylate synthase (TS) and excision repair cross-complementing group 1 (ERCC1) immunohistochemical expression in malignant pleural mesothelioma patients treated with pemetrexed and carboplatin
    Zucali, P.
    Destro, A.
    Ceresoli, G. L.
    Gianoncelli, L.
    Lorenzi, E.
    De Vincenzo, F.
    Simonelli, M.
    Giordano, L.
    Roncalli, M.
    Santoro, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 543 - 543
  • [27] EXPRESSION AND PROGNOSTIC ROLE OF EXCISION REPAIR CROSS COMPLEMENTING GROUP 1 (ERCC1) IN EARLY STAGE BREAST CANCER (BC) PATIENTS (PTS)
    Minenza, Elisa
    Colozza, Mariantonietta
    Sidoni, Angelo
    Gori, Stefania
    Sormani, Maria Pia
    Cartaginese, Fabio
    Fenocchio, Daniela
    Azienda, Lucio Crino L.
    ANNALS OF ONCOLOGY, 2009, 20
  • [28] Analysis of excision repair cross complementing group 1 (ERCC1) expression in squamous cell carcinoma of the head and neck (SCCHN)
    Mehra, Ranee
    Cai, Qi K.
    Zhu, Fang
    Godwin, Andrew
    Burtness, Barbara
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [29] EXCISION REPAIR CROSS-COMPLEMENTING 1 AS A NOVEL MARKER IN BLADDER CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY
    Nomura, Shunichiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A227 - A227
  • [30] Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912
    Yamada, Y.
    Boku, N.
    Nishina, T.
    Yamaguchi, K.
    Denda, T.
    Tsuji, A.
    Hamamoto, Y.
    Konishi, K.
    Tsuji, Y.
    Amagai, K.
    Ohkawa, S.
    Fujita, Y.
    Nishisaki, H.
    Kawai, H.
    Takashima, A.
    Mizusawa, J.
    Nakamura, K.
    Ohtsu, A.
    ANNALS OF ONCOLOGY, 2013, 24 (10) : 2560 - 2565
12345